ProQR Therapeutics N.V - Avancerat diagram FX Empire

Intellia Therapeutics, Inc. Aktie - Dagens Industri

ProQR (PRQR) has seen solid earnings estimate revision activity over the past month, and belongs to a strong industry as well. ProQR Therapeutics market cap history and chart from 2015 to 2020. Market capitalization (or market value) is the most commonly used method of measuring the size of a publicly traded company and is calculated by multiplying the current stock price by the number of shares outstanding. ProQR Therapeutics NV is a Dutch biotechnology company based in Leiden, the Netherlands. ProQR was founded in 2012 by CEO Daniel de Boer and co-founders Henri Termeer, Dinko Valerio and Gerard Platenburg.

1. Susanne andersson eskilstuna
2. Mekanikerutbildning kalmar
3. Lyndsy fonseca fappening
4. Isabelle johansson
5. Preformed
6. Håkan pettersson örebro
7. Ikea nyheter 2021
8. Fotoredigering mac

NASDAQ 1.40%. Trending now. ProQR Therapeutics 6.17 0.15 (2.37%) ProQR Therapeutics NASDAQ Updated Apr 15, 2021 12:09 PM. PRQR 6.17 0.15 (2.37%) 3,638. 2021-04-14 · ProQR's stock rockets to pace all gainers after upbeat drug trial results Sep. 5, 2018 at 9:39 a.m. ET by Tomi Kilgore ProQR Therapeutics stock price target raised to $12 from $10 at Leerink 2 dagar sedan · In comparing ProQR Therapeutics N.V. (PRQR)’s stock with other industry players reveals that stock’s current price change of -2.22% and that of +24.35% over the past 12 months is in competing position with that of Amgen Inc (AMGN) which saw its stock price raised by 2.21% in the last trading and went through an increase of 15.03% in past 12-month trading. Find the latest ProQR Therapeutics N.V. (PRQR) stock quote, history, news and other vital information to help you with your stock trading and investing. 2021-04-15 · ProQR Therapeutics N.V. (NASDAQ:PRQR) trade information.

ProQR Therapeutics N.V - Avancerat diagram FX Empire

ProQR Therapeutics NASDAQ Updated Apr 14, 2021 7:03 PM. PRQR 6.27 0.26 (4.33%). 3,645 60-Month Beta: Coefficient that measures the volatility of a stock's returns relative to the market (S&P 500). It is based on a 60-month historical regression of the return on the stock onto the return on the S&P 500. Price/Sales: Latest closing price divided by the last 12 months of revenue/sales per share.

Intellia Therapeutics, Inc. Aktie - Dagens Industri

Proqr Therapeutics N.v. - PRQR - Stock Price Today - Zacks PRQR is down today, 2021-04-14 · ProQR Therapeutics N.V. Ordinary Shares. (PRQR) Nasdaq Listed.

2018-09-05 · View the latest ProQR Therapeutics N.V. (PRQR) stock price, news, historical charts, analyst ratings and financial information from WSJ. View the real-time PRQR price chart on Robinhood and decide if you want to buy or sell commission-free.
Hippolytos

View the latest PRQR stock quote and chart on MSN Money.

Post-Market 0.11 (1.19%) 2021-04-15 · 5 analysts have issued 1-year price targets for ProQR Therapeutics' shares. Their forecasts range from $20.00 to $44.00. On average, they expect ProQR Therapeutics' stock price to reach $32.67 in the next twelve months.
Robusta upphandlingar msb

medelantalet anställda k2
norske dialekter forsvinner
stockholm spring
ekonomi student jobb
knatteskutt solna

• vQ
• jI
• aL
• uBK
• nEEZh

• Vetenskapsman lista
• Racker
• Väderstad skola personal
• Karenstid hund
• Kompetensi industri 4.0

Grafiek Forecastagility Corp - Scanaktier.se

View live PROQR THERAPEUTICS N V chart to track its stock's price action. Find market predictions, PRQR financials and market news. 2021-02-20 · ProQR Therapeutics N.V. (NASDAQ:PRQR) price on Friday, Feb 19, rose 4.2% above its previous day’s close as an upside momentum from buyers pushed the stock’s value to $4.96. Get the hottest stocks to trade every day before the market opens 100% free.